| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e9e0b17a7397b2f1b810b713a0e7651 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01F7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01F7-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6949 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01F7-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01F7-02 |
| filingDate |
2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3010bc89b49f4db03e18ece0b46caf5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496bd92bbc1fd1691e83de1a7a1488fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f7f019c0443be5c93ea411430e2e6b |
| publicationDate |
2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017172887-A1 |
| titleOfInvention |
Intravenous administration of a solution comprising poly-oxygenated metal hydroxide |
| abstract |
Use of a poly-oxygenated metal hydroxide composition comprising a clathrate containing free oxygen gas (02) molecules in the preparation of a solution for increasing interstitial tissue oxygenation PO2. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 100 um to prevent an immune response and prevent loss from a blood vessel. The poly-oxygenated aluminum hydroxide may be 75-90% colloid or crystalline solution with 10-25% addition of poly-oxygenated aluminum hydroxide particles. The use of the composition may be for a depletion of hemoglobin wherein the poly-oxygenated aluminum hydroxide acts as an oxygen resuscitative fluid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10624841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018256458-B2 |
| priorityDate |
2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |